Case Report: The Added Value of Liquid Biopsy in Advanced Colorectal Cancer From Clinical Case Experiences
Liquid biopsy represents a valid strategy for tumor molecular characterization. It gives the opportunity to bypass tumor heterogeneity, to monitor tumor characteristics during the course of treatment, and to perform the analysis even when tumor tissue is not available or inadequate. In the clinical...
Guardado en:
Autores principales: | Paola Ulivi, Alessandro Passardi, Giorgia Marisi, Elisa Chiadini, Chiara Molinari, Matteo Canale, Luigi Pasini, Fabio Ferroni, Giovanni Luca Frassineti, Giulia Bartolini, Manlio Monti |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/83b520a2d9594b96bbf750402e9697ce |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact
por: Natasha Honoré, et al.
Publicado: (2021) -
Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer
por: Veldore VH, et al.
Publicado: (2018) -
Rational Development of Liquid Biopsy Analysis in Renal Cell Carcinoma
por: Kate I. Glennon, et al.
Publicado: (2021) -
Editorial: Ras and Other GTPases in Cancer: From Basic to Applied Research
por: Kwang-jin Cho, et al.
Publicado: (2021) -
Plasma-Based Genotyping in Advanced Solid Tumors: A Comprehensive Review
por: Maisam Makarem, et al.
Publicado: (2021)